Antithrombotic therapy in diabetes: which, when, and for how long?

Cardiovascular disease remains the main cause of mortality in individuals with diabetes mellitus (DM) and also results in significant morbidity. Premature and more aggressive atherosclerotic disease, coupled with an enhanced thrombotic environment, contributes to the high vascular risk in individual...

Descripción completa

Detalles Bibliográficos
Autores principales: Ajjan, Ramzi A, Kietsiriroje, Noppadol, Badimon, Lina, Vilahur, Gemma, Gorog, Diana A, Angiolillo, Dominick J, Russell, David A, Rocca, Bianca, Storey, Robert F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
State of the Art Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203081/
https://www.ncbi.nlm.nih.gov/pubmed/33764414
http://dx.doi.org/10.1093/eurheartj/ehab128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203081/
https://www.ncbi.nlm.nih.gov/pubmed/33764414
http://dx.doi.org/10.1093/eurheartj/ehab128

Ejemplares similares